1. Alcendor DJ, Knobel SM, Desai P et al (2009) KSHV downregulation of galectin-3 in Kaposi’s sarcoma. Glycobiology 20:521–532.
2. Aron M, Kapila K, Verma K (2006) Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms. Indian J Pathol Microbiol 49:376–380
3. Baptiste TA, James A, Saria M, Ochieng J (2007) Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin. Exp Cell Res 313:652–664
4. Barroeta JE, Baloch ZW, Lal P et al (2006) Diagnostic value of differential expression of CK19, galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocr Pathol 17:225–234, Fall
5. Bartik P, Maglott A, Entlicher G et al (2008) Detection of a hypersialylated beta1 integrin endogenously expressed in the human astrocytoma cell line A172. Int J Oncol 32:1021–1031